Madrigal Pharmaceuticals, Inc. (MDGL)
552.36
-1.56
(-0.28%)
USD |
NASDAQ |
Dec 10, 16:00
552.55
+0.19
(+0.03%)
After-Hours: 16:28
Madrigal Pharmaceuticals Total Assets (Quarterly): 1.362B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Amgen, Inc. | 90.14B |
| Alnylam Pharmaceuticals, Inc. | 4.852B |
| Amicus Therapeutics, Inc. | 868.81M |
| Insmed, Inc. | 2.361B |
| Ionis Pharmaceuticals, Inc. | 3.033B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 736.72M |
| Shareholders Equity (Quarterly) | 625.73M |
| Debt to Equity Ratio | 0.5536 |
| Current Ratio | 3.441 |
| Net Debt Paydown Yield | -0.44% |